Rockefeller Capital Management L.P.
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1739439
NEW YORK, NY
Position in VRTX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$66,826,941
+$5,518,164 QoQ
Shares Held
149,655
+10.7% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 80.07270103037673.ToString("F0")%
Shared 0.ToString("F0")%
None 19.927298969623266.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Rockefeller Capital Management L.P. holds $285,796,172 across 243 Biotechnology names. VRTX ranks #1 (23.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
149,655 | $66,826,941 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
249,174 | $47,106,343 | |
| 3 | PTCT |
Ptc Therapeutics, Inc.
|
384,672 | $26,207,702 | |
| 4 | ACAD |
Acadia Pharmaceuticals Inc
|
1,027,357 | $22,868,965 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
28,520 | $22,035,691 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
372,197 | $21,025,406 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
33,849 | $17,718,934 | |
| 8 | CORT |
Corcept Therapeutics Inc
|
123,497 | $4,978,162 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $66,826,941 | 149,655 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $61,308,777 | 135,232 | Shares | Defined | 2026-03-17 | |
| 2025-09-30 | $36,349,673 | 92,814 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $44,403,355 | 99,738 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $44,101,164 | 90,964 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $39,782,329 | 98,789 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $32,810,927 | 70,549 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $33,354,583 | 71,161 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $29,210,955 | 69,881 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $24,627,017 | 60,525 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $18,391,967 | 52,890 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $18,096,266 | 51,423 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $14,407,519 | 45,728 | Shares | Defined | 2023-05-16 | |
| 2022-12-31 | $13,729,755 | 47,544 | Shares | Defined | 2023-03-06 | |
| 2022-09-30 | $13,835,668 | 47,785 | Shares | Defined | 2022-11-02 | |
| 2022-06-30 | $12,107,670 | 42,967 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $9,637,099 | 36,928 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $6,614,571 | 30,121 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $4,330,323 | 23,873 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $3,507,554 | 17,396 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $4,027,467 | 18,742 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $2,729,962 | 11,551 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $2,980,258 | 10,952 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $3,048,255 | 10,500 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $1,955,473 | 8,218 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||